Skip to content

Y-mAbs Therapeutics, Inc.

Delisted

CIK 1722964fmd_0E8DAJC6A7ZN0E0V4PVRDQCYEBManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2016 to Jun 30, 2025, 35 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading